Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis

Dupixent included in list of overseas approved drugs that meet urgent clinical need in China Dupixent is approved in 60 countries for adults with moderate-to-severe atopic dermatitis, one of the diseases driven by type 2 inflammation TARRYTOWN, N.Y. ... Biopharmaceuticals, Dermatology, Regulatory Regeneron Pharmaceuticals, Sanofi, Dupixent, dupilumab, atopic dermatitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news